-
1 Comment
HAEMATO AG is currently in a long term uptrend where the price is trading 10.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Based on the above factors, HAEMATO AG gets an overall score of 2/5.
Sector | |
---|---|
Industry | |
ISIN | DE000A289VV1 |
Exchange | F |
CurrencyCode | EUR |
Market Cap | 79M |
---|---|
PE Ratio | 8.14 |
Target Price | None |
Dividend Yield | 8.0% |
Beta | 1.29 |
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. It operates through Specialty Pharma and Lifestyle & Aesthetics segments. The company engages in the development, acquisition, licensing, and distribution of prescription drugs and OTC products, special cosmetics, as well as dietary supplements. In addition, it provides pharmaceuticals in the areas of HIV/AIDS, neurology, oncology, and rheumatology diseases. Further, the company develops, manufactures, and distributes diagnostic tests under the HAEMATO brand, and cosmetics under the brand M1 SELECT, as well as supplies third party-products. It serves clinics, pharmacies, wholesalers, and medical test centers. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HAEK.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025